TY - JOUR
T1 - Laboratory diagnosis of infective endocarditis
AU - Liesman, Rachael M.
AU - Pritt, Bobbi S.
AU - Maleszewski, Joseph J.
AU - Patela, Robin
N1 - Funding Information:
R.P. reports grants from BioFire, Check-Points, Curetis, 3M, Merck, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, Allergan, and The Medicines Company. R.P. is a consultant to Curetis, Roche, Qvella, and Diaxonhit. In addition, R.P. has a patent on a Bordetella pertussis/B. parapertussis PCR assay with royalties paid by TIB, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, and a patent on an antibiofilm substance issued. R.P. serves on an Actelion data monitoring board. R.P. receives travel reimbursement and an editor’s stipend from ASM and IDSA and honoraria from the USMLE, Up-to-Date, and the Infectious Diseases Board Review Course.
Publisher Copyright:
Copyright © 2017 American Society for Microbiology.
PY - 2017/9
Y1 - 2017/9
N2 - Infective endocarditis is life-threatening; identification of the underlying etiology informs optimized individual patient management. Changing epidemiology, advances in blood culture techniques, and new diagnostics guide the application of laboratory testing for diagnosis of endocarditis. Blood cultures remain the standard test for microbial diagnosis, with directed serological testing (i.e., Q fever serology, Bartonella serology) in culture-negative cases. Histopathology and molecular diagnostics (e.g., 16S rRNA gene PCR/sequencing, Tropheryma whipplei PCR) may be applied to resected valves to aid in diagnosis. Herein, we summarize recent knowledge in this area and propose a microbiologic and pathological algorithm for endocarditis diagnosis.
AB - Infective endocarditis is life-threatening; identification of the underlying etiology informs optimized individual patient management. Changing epidemiology, advances in blood culture techniques, and new diagnostics guide the application of laboratory testing for diagnosis of endocarditis. Blood cultures remain the standard test for microbial diagnosis, with directed serological testing (i.e., Q fever serology, Bartonella serology) in culture-negative cases. Histopathology and molecular diagnostics (e.g., 16S rRNA gene PCR/sequencing, Tropheryma whipplei PCR) may be applied to resected valves to aid in diagnosis. Herein, we summarize recent knowledge in this area and propose a microbiologic and pathological algorithm for endocarditis diagnosis.
KW - Clinical microbiology
KW - Endocarditis
UR - http://www.scopus.com/inward/record.url?scp=85028306342&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85028306342&partnerID=8YFLogxK
U2 - 10.1128/JCM.00635-17
DO - 10.1128/JCM.00635-17
M3 - Review article
C2 - 28659319
AN - SCOPUS:85028306342
SN - 0095-1137
VL - 55
SP - 2599
EP - 2608
JO - Journal of Clinical Microbiology
JF - Journal of Clinical Microbiology
IS - 9
ER -